General Information of the Compound
Compound ID |
CP0022915
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-Phenyl-benzo[d]isoselenazol-3-one
Show/Hide
|
||||||||||||||||||
Synonyms |
2-Phenyl-1,2-benzisoselenazol-3(2H)-one
2-Phenyl-1,2-benzisoselenazolin-3-one
2-phenyl-1,2-benzoisoselenazol-3(2H)-one
2-phenyl-1,2-benzoselenazol-3-one
DR 3305
DR-3305
E 3520
Ebselen [INN]
Ebselene
Ebselene [French]
Ebseleno
Ebseleno [Spanish]
Ebselenum
Ebselenum [Latin]
Harmokisane
PMID25468267-Compound-30
PZ 51
PZ-51
PZ51
RP 60931
SPI-1005
SPI-3005
Selenium compound 3
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C13H9NOSe
|
||||||||||||||||||
Molecular Weight |
274.181
|
||||||||||||||||||
Canonical SMILES |
O=c1n([se]c2ccccc12)-c1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C13H9NOSe/c15-13-11-8-4-5-9-12(11)16-14(13)10-6-2-1-3-7-10/h1-9H
Show/Hide
|
||||||||||||||||||
InChIKey |
DYEFUKCXAQOFHX-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
60940-34-3
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06109, Geminin
Protein ID: PT02997, Isocitrate dehydrogenase [NADP] cytoplasmic
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Clinical Information about the Compound
Drug 1 ( Selenium compound 3 )
Drug Name | Selenium compound 3 | ||
---|---|---|---|
Company | ISIS INNOVATION LIMITED SCHOFIELD, Christopher Joseph ROSE, Nathan SEKIRNIK, Rok | ||
Target(s) |
Drug 2 ( SPI-1005 )
Drug Name | SPI-1005 | ||
---|---|---|---|
Indication | |||
Target(s) |